EA201300947A1 - Композиция для повышения устойчивости суставов и/или позной устойчивости - Google Patents

Композиция для повышения устойчивости суставов и/или позной устойчивости

Info

Publication number
EA201300947A1
EA201300947A1 EA201300947A EA201300947A EA201300947A1 EA 201300947 A1 EA201300947 A1 EA 201300947A1 EA 201300947 A EA201300947 A EA 201300947A EA 201300947 A EA201300947 A EA 201300947A EA 201300947 A1 EA201300947 A1 EA 201300947A1
Authority
EA
Eurasian Patent Office
Prior art keywords
stability
composition
joints
positive
increasing
Prior art date
Application number
EA201300947A
Other languages
English (en)
Inventor
Клаудиа Шольц
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA201300947A1 publication Critical patent/EA201300947A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение касается композиции для применения с целью повышения устойчивости суставов или позной устойчивости, причем вышеупомянутая композиция включает разветвленные аминокислоты. Оно также касается применения разветвленных аминокислот для изготовления пищевой добавки или медикаментов для профилактики и/или лечения неустойчивости суставов и/или позной неустойчивости.
EA201300947A 2011-02-25 2012-02-03 Композиция для повышения устойчивости суставов и/или позной устойчивости EA201300947A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11001570 2011-02-25
PCT/EP2012/000490 WO2012113503A1 (en) 2011-02-25 2012-02-03 Composition to increase joint and/or postural stability

Publications (1)

Publication Number Publication Date
EA201300947A1 true EA201300947A1 (ru) 2014-02-28

Family

ID=45607186

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300947A EA201300947A1 (ru) 2011-02-25 2012-02-03 Композиция для повышения устойчивости суставов и/или позной устойчивости

Country Status (12)

Country Link
US (1) US20130330423A1 (ru)
EP (1) EP2678010A1 (ru)
JP (1) JP2014507437A (ru)
KR (1) KR20140007926A (ru)
CN (1) CN103370062A (ru)
AU (1) AU2012220068A1 (ru)
BR (1) BR112013021376A2 (ru)
CA (1) CA2828134A1 (ru)
EA (1) EA201300947A1 (ru)
MX (1) MX2013009643A (ru)
WO (1) WO2012113503A1 (ru)
ZA (1) ZA201307146B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016182262A2 (ko) * 2015-05-14 2016-11-17 주식회사 아모레퍼시픽 관절 기능 향상용 조성물
KR102621217B1 (ko) 2015-05-14 2024-01-05 (주)아모레퍼시픽 관절 기능 향상용 조성물
JPWO2020009191A1 (ja) * 2018-07-04 2021-08-02 味の素株式会社 高齢動物の疼痛緩和用アミノ酸含有組成物
KR102287247B1 (ko) * 2020-12-24 2021-08-06 양소현 반려동물 관절 영양제 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
JP2001169752A (ja) * 1999-12-15 2001-06-26 Fancl Corp 食品組成物
EP1358878A1 (en) * 2001-01-30 2003-11-05 Ajinomoto Co., Inc. Remedies/preventives for inflammatory diseases
BRPI0619179A2 (pt) * 2005-11-30 2011-09-13 Nestec Sa métodos para o tratamento de perda muscular
US7982066B2 (en) * 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
EP2456448A1 (en) * 2009-07-20 2012-05-30 Nestec S.A. Methods of attenuating the loss of functional status

Also Published As

Publication number Publication date
AU2012220068A1 (en) 2013-10-10
CA2828134A1 (en) 2012-08-30
US20130330423A1 (en) 2013-12-12
JP2014507437A (ja) 2014-03-27
MX2013009643A (es) 2013-09-26
ZA201307146B (en) 2014-12-23
KR20140007926A (ko) 2014-01-20
BR112013021376A2 (pt) 2016-10-18
EP2678010A1 (en) 2014-01-01
WO2012113503A1 (en) 2012-08-30
CN103370062A (zh) 2013-10-23

Similar Documents

Publication Publication Date Title
MD20140134A2 (ru) Соединения D-аминокислот для лечения болезней печени
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
IN2014DN10386A (ru)
MX2017001279A (es) Usos y composiciones de la flagelina.
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
MX2013001677A (es) Formulaciones estables de linaclotida.
EA201790109A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
IN2015DN03322A (ru)
EA201270018A1 (ru) Опсинсвязывающие лиганды, композиции и способы использования
MX339666B (es) Composiciones y metodos para estabilizar formulaciones que contienen proteinas.
MY167804A (en) Treatment of degenerative joint disease
EP3760638A3 (en) Compositions and methods utilizing lysophosphatidylcholine scaffolds
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
MX342947B (es) Tratamiento de diabetes tipo 2.
IN2014DN03213A (ru)
PH12014501200A1 (en) Bacteriophage gene 3 protein compositions and use as amyloid binding agents
EA201592003A1 (ru) Микропищевые добавки для иммунитета
EA201300947A1 (ru) Композиция для повышения устойчивости суставов и/или позной устойчивости
MY191337A (en) Compositions for the treatment of hypertension and/or fibrosis
IN2014DN07326A (ru)
IT1397446B1 (it) Compositions comprising amino acids for prevention and/or treatment of renal disorders.
MX2019012375A (es) Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1).
WO2014104989A8 (en) Pharmaceutical compositions comprising aripiprazole
MX2016006790A (es) Producto cosmetico con propiedades reparadoras del adn.